“中國正畸第一股”時代天使(6699.HK)首日上市收漲131.79% 成交58億位居港股第一
格隆匯6月16日丨時代天使(6699.HK)今日首日上市,盤中最高漲183.24%報490港元,最終收漲131.79%報401港元,全天成交58.78億港元,位居港股市場第一位,換手率8.96%,市值665億港元。 時代天使是國內領先的隱形矯治解決方案提供商,市佔率41.3%,與橫掃全球的國際巨頭Align Technology(艾利科技/隱適美)分庭抗衡,形成雙寡頭競爭格局。分析人士指出,市場之所以如此看好時代天使,主因競爭對手艾利科技(ALGN.US)在過去的10多年裏股價暴漲,是美股中名副其實的大牛股。截至6月15日收盤,艾利科技總市值475億美元(約合3687億港元)。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.